New Tools for Science Policy

The Case for Understanding Biomedical Innovation Better

About the Seminar

March 21, 2017 8:30am—10:00am

As pressure once again ratchets up on domestic discretionary spending, the national debate about drug pricing (and the cost of health care in general) intensifies, and discussion of tax policy for repatriating billions of profits parked abroad, are there opportunities for using policy to reconfigure incentives for biomedical innovation that better align investments with health outcomes?